复发性卵巢癌表现为孤立性胸壁转移:FDG PET/CT 揭示
Recurrent Ovarian Cancer Presenting as a Solitary Chest Wall Metastasis Revealed by FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2022-01-01
一名4年前诊断为卵巢癌的55岁女性因背痛1个月就诊,CA-125水平升高,行FDG PET/CT再分期,显示右侧后胸壁高代谢肿块,术后病理证实为卵巢癌转移。
要点
- 卵巢癌患者出现背痛及CA-125升高时应考虑转移可能。
- FDG PET/CT可发现孤立性胸壁高代谢转移灶。
- 术后病理证实胸壁肿块为卵巢癌转移。
核心结论
- FDG PET/CT在卵巢癌再分期中揭示了右侧后胸壁孤立性高代谢转移灶,术后病理证实为卵巢癌转移。
研究设计与样本
- 病例报告:一名55岁女性,4年前诊断为卵巢癌,因背痛1个月且CA-125升高行FDG PET/CT再分期。
主要发现
- FDG PET/CT显示右侧后胸壁高代谢肿块,术后病理证实为卵巢癌转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 55-year-old woman who was diagnosed with ovarian cancer 4 years ago complained of back pain for 1 month, and the CA-125 level was elevated. FDG PET/CT was then performed for restaging, and the images revealed a hypermetabolic mass in the right posterior chest wall. Postsurgical pathology confirmed metastasis from ovarian cancer.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Shen G, Kuang A. Recurrent Ovarian Cancer Presenting as a Solitary Chest Wall Metastasis Revealed by FDG PET/CT. Clin Nucl Med. 2022. PMID: 35143461. doi:10.1097/RLU.0000000000003958
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。